The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Interim analysis of a phase I study using cryopreserved non-genetically modified allogeneic natural killer cells with enhanced cytotoxicity (SNK02) in patients with advanced solid tumors without lymphodepletion.
 
Victoria Chua
Research Funding - NKGen Biotech
 
Sant P. Chawla
Stock and Other Ownership Interests - AADi; Cellestia Biotech; Counterpoint; Immix BioPharma
Honoraria - Advenchen Laboratories; Amgen; Bayer; CytRx Corporation; GlaxoSmithKline; Ignyta; Immune Design; InhibRx; Janssen; Karyopharm Therapeutics; NKMax; NKMax; Roche; SARC: Sarcoma Alliance for Research though Collaboration; Threshold Pharmaceuticals; TRACON Pharma; Tyme
Consulting or Advisory Role - Advenchen Laboratories; Amgen; Bayer; CytRx Corporation; GlaxoSmithKline; Ignyta; Immune Design; InhibRx; Janssen; Karyopharm Therapeutics; NKMax; Roche; SARC: Sarcoma Alliance for Research though Collaboration; Threshold Pharmaceuticals; TRACON Pharma
Speakers' Bureau - Amgen; CytRx Corporation; GlaxoSmithKline; Ignyta; Immune Design; Janssen; Karyopharm Therapeutics; Roche; SARC: Sarcoma Alliance for Research though Collaboration; Threshold Pharmaceuticals; TRACON Pharma
Research Funding - Advenchen Laboratories; Amgen; Bayer; CytRx Corporation; GlaxoSmithKline; Ignyta; Immune Design; InhibRx; Janssen; Janssen; Karyopharm Therapeutics; NKMax; Roche; SARC: Sarcoma Alliance for Research though Collaboration; Threshold Pharmaceuticals; TRACON Pharma
 
Erlinda Maria Gordon
Stock and Other Ownership Interests - Counterpoint Biomedica; Delta Next-Gene
Research Funding - Jazz Pharmaceuticals
Patents, Royalties, Other Intellectual Property - Co-inventor of patents on targeting pharmaceutical agents to injured tissues
Travel, Accommodations, Expenses - Immix BioPharma
 
William Feske
No Relationships to Disclose
 
Lucia Hui
Employment - NKGen Biotech
Stock and Other Ownership Interests - NKGen Biotech
 
Hank Lee
Employment - NKGen Biotech
Stock and Other Ownership Interests - NKGen Biotech
 
Yoonmi Kang
Employment - NKGen Biotech
Stock and Other Ownership Interests - NKGen Biotech
 
Juan Mata
Employment - NKGen Biotech
Stock and Other Ownership Interests - NKGen Biotech
 
Katia Betito
Employment - NKGen Biotech
Stock and Other Ownership Interests - NKGen Biotech
 
Paul Y. Chang
Employment - NKGen Biotech
Stock and Other Ownership Interests - NKGen Biotech
 
Paul Y. Song
Employment - NkGen Biotech
Leadership - NkGen Biotech
Stock and Other Ownership Interests - NkGen Biotech
Consulting or Advisory Role - Pepromene